
Evoke Pharma EVOK
Quartalsbericht 2025-Q3
hinzugefügt 13.11.2025
Evoke Pharma DIO 2011-2026 | EVOK
DIO Jährlich Evoke Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 995 | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 995 | 995 | 995 |
DIO anderer Aktien in der Arzneimittelhersteller
| Name | DIO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agile Therapeutics
AGRX
|
82.7 | - | 10.11 % | $ 58.2 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
133 | - | 7.5 % | $ 6.35 M | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
48.9 | - | 0.86 % | $ 117 M | ||
|
Aerie Pharmaceuticals
AERI
|
459 | - | - | $ 754 M | ||
|
Catalent
CTLT
|
71.9 | - | - | $ 11.5 B | ||
|
DURECT Corporation
DRRX
|
460 | - | - | $ 50.1 M | ||
|
Alimera Sciences
ALIM
|
58.7 | - | - | $ 142 M | ||
|
Athenex
ATNX
|
158 | - | -23.39 % | $ 1.76 M | ||
|
Eagle Pharmaceuticals
EGRX
|
149 | - | -39.89 % | $ 27.7 M | ||
|
Endo International plc
ENDP
|
100 | - | - | $ 28.9 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
366 | - | - | $ 2.06 B | ||
|
Cumberland Pharmaceuticals
CPIX
|
239 | $ 3.13 | 1.29 % | $ 44 M | ||
|
Cronos Group
CRON
|
221 | $ 2.59 | 0.19 % | $ 1.35 B | ||
|
HEXO Corp.
HEXO
|
703 | - | 2.45 % | $ 38.1 M | ||
|
Bausch Health Companies
BHC
|
172 | $ 5.73 | 2.32 % | $ 2.09 B | ||
|
Harrow Health
HROW
|
65.1 | $ 37.01 | 3.01 % | $ 1.36 B | ||
|
Aurora Cannabis
ACB
|
1.35 K | $ 3.51 | 2.19 % | $ 86.3 M | ||
|
Canopy Growth Corporation
CGC
|
167 | $ 1.09 | 3.81 % | $ 117 M | ||
|
Tilray
TLRY
|
170 | $ 6.72 | 2.28 % | $ 4.15 B | ||
|
OrganiGram Holdings
OGI
|
2.83 K | $ 1.44 | 2.5 % | $ 402 M | ||
|
Jupiter Wellness
JUPW
|
80.2 | - | - | $ 33.6 M | ||
|
Lannett Company
LCI
|
127 | - | 1.15 % | $ 7.11 M | ||
|
Veru
VERU
|
179 | $ 2.39 | 0.42 % | $ 322 M | ||
|
Viatris
VTRS
|
140 | $ 13.79 | 2.38 % | $ 16.6 B | ||
|
Evolus
EOLS
|
71.3 | $ 4.31 | 0.94 % | $ 278 M | ||
|
Emergent BioSolutions
EBS
|
176 | $ 8.23 | 3.39 % | $ 421 M | ||
|
Organogenesis Holdings
ORGO
|
85.9 | $ 2.41 | 1.26 % | $ 317 M | ||
|
Pacira BioSciences
PCRX
|
246 | $ 24.06 | 1.13 % | $ 1.11 B | ||
|
PetIQ
PETQ
|
64.9 | - | 1.64 % | $ 400 M | ||
|
ProPhase Labs
PRPH
|
30.1 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
322 | $ 18.02 | - | $ 115 M | ||
|
cbdMD
YCBD
|
165 | $ 0.73 | 7.72 % | $ 3.15 M | ||
|
Radius Health
RDUS
|
204 | - | - | $ 1.42 B | ||
|
Recro Pharma
REPH
|
49.1 | - | -4.76 % | $ 65.3 M | ||
|
OptiNose
OPTN
|
370 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
97.2 | - | -27.8 % | $ 2.56 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
117 | $ 2.27 | -0.44 % | $ 2.82 M | ||
|
Zomedica Corp.
ZOM
|
187 | - | -0.21 % | $ 98 M | ||
|
Rockwell Medical
RMTI
|
29.2 | $ 0.91 | 0.41 % | $ 32.7 M | ||
|
China Pharma Holdings
CPHI
|
166 | $ 0.65 | 0.62 % | $ 2.79 M | ||
|
TherapeuticsMD
TXMD
|
1.04 K | $ 2.0 | -3.38 % | $ 23.1 M |